Opportunity
Simpler Grants.gov #HT942526LRPTVDA
Lupus Research Program Transformative Vision Development Award Grant Opportunity
Buyer
Dept. of the Army -- USAMRAA
Posted
May 05, 2026
Respond By
August 24, 2026
Identifier
HT942526LRPTVDA
NAICS
541715
This opportunity invites applications for the Lupus Research Program Transformative Vision Development Award (TVDA), managed by the Defense Health Agency's Congressionally Directed Medical Research Programs (CDMRP). - Government Buyer: - Defense Health Agency (DHA), through the Defense Health Agency Research and Development (DHA R&D) and the Defense Health Agency Contracting Activity (DHACA) - Program Details: - Supports planning, development, and pilot studies to generate preliminary data for future interventional lupus research - Focus on innovative healthcare delivery models to improve quality of life for lupus patients - Approximately two awards available, each up to $250,000 in total funding - Maximum period of performance is 2 years per award - Eligibility and Requirements: - Open to U.S. Department of War organizations and affiliated investigators - Applications must include at least one lupus consumer advocate as a research team member - Research may include phase 0/1 clinical trials but excludes phase 2/3 clinical trials and animal studies - No specific OEMs or vendors are mentioned, as this is a research grant opportunity, not a product or equipment procurement
Description
This funding mechanism supports planning and development activities and pilot studies that will generate preliminary data and demonstrate feasibility for achieving the aims of a future interventional study. Successful studies may be submitted to a future Lupus Research Program (LRP) Transformative Vision Award (TVA), or equivalent, for funding consideration. Research must address at least one of the fiscal year 2026 (FY26) LRP Transformative Vision Development Award (TVDA) focus areas. The mechanism allows for phase 0/1 clinical trials but does not allow for phase 2/3 clinical trials or animal studies. Applications must include at least one lupus consumer advocate as a member of the research team.